ANTIHYPERTENSIVE DRUG UTILISATION PATTERN AMONG CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING MAINTENANCE DIALYSIS IN A TERTIARY CARE TEACHING HOSPITAL
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2016, Vol 5, Issue 50
Abstract
BACKGROUND The world is facing a global epidemic of Chronic Kidney Disease (CKD), a major threat to health in general because of an increasing incidence, high cost of treatment and poor outcome associated with various adverse events and comorbidities. Although improved control of hypertension is known to attenuate progression of Chronic Kidney Disease (CKD), a little is known about the adequacy of treatment of hypertension in patients with CKD in India. AIM To analyse the utilisation pattern of anti-hypertensive agents in patients with Chronic Kidney Disease in a tertiary care teaching Hospital. MATERIAL AND METHODS A descriptive prospective study was conducted in the Department of Nephrology, S. C. B. Medical College and Hospital, Cuttack, for a period of 6 months from 1st January 2015 to 30th June 2015. Relevant patient information, data regarding AntiHypertensive Drugs Utilization pattern entered in a preformed proforma in Microsoft Excel sheet for compilation and subjected to statistical analysis. RESULTS Total 100 case records were analysed. Mean age was 55.37±13.41 years. Male-female ratio was 2.7. Maximum number of patients were from age group 51-60 years (43%) followed by age group 41-50 years (29%). All the patients (100%) were hypertensives, among which 42% patients of the study population were diabetic with hypertension and rest of the patients (58%) were non-diabetic with hypertension. Routinely prescribed anti-hypertensives are CCB, β blockers, diuretics, α blockers, ACEI and centrally acting sympatholytics. Among them, Calcium Channel Blockers (32.47%) were most frequently used followed by β Blockers (24.78%), Diuretics (23.50%), Centrally Acting Sympatholytics (10.25%), α Blockers (7.69%) and ACE Inhibitors (1.28%). Hypertension in CKD patients was very difficult to manage. Approximately, two-third of the patients (66%) had BP >140/90 mmHg with anti-hypertensive therapy. Targeted blood pressure control was present in (34%) of the patients. CONCLUSION Control of hypertension is poor in participants with CKD and that lack of control is primarily Systolic Hypertension. So a permutation and combination of various anti-hypertensive agents were used in CKD patients undergoing maintenance dialysis
Authors and Affiliations
Ansuman P, Rajendra , Jigyansa , Namita , Srikanta
Keywords
Related Articles
- EP ID EP159622
- DOI 10.14260/jemds/2016/744
- Views 70
- Downloads 0
ROLE OF MINI PCNL IN THE TREATMENT OF RENAL AND UPPER URETERIC CALCULUS
BACKGROUND In this article we describe our institutional experience with mini PCNL, in particular the indications, results and the complications of this method. MATERIALS AND METHODS It is a prospective observational stu...
KNOWLEDGE OF MEDICAL PROFESSIONALS TOWARDS DENGUE DIAGNOSTICS
Dengue is a major public health problem throughout the world. It is a rapidly spreading mosquito-borne viral disease with high rate of morbidity and mortality. Dengue can be reduced by implementing early case det...
PREVALENCE OF OBSTRUCTIVE SLEEP APNOEA IN ODISHA POPULATION- A CAMP BASED QUESTIONNAIRE SURVEY
BACKGROUND Obstructive sleep apnoea (OSA) is a disorder of most serious form among the sleep disordered breathing, which has become highly prevalent and negatively affects the quality of life. Its prevalence globally is...
COMPARATIVE STUDY OF TRANSVERSUS ABDOMINIS PLANE (TAP) BLOCK VERSUS LOCAL ANAESTHETIC WOUND INFILTRATION FOR POST-OPERATIVE PAIN RELIEF
BACKGROUND A major contributor to pain experienced after abdominal surgeries is pain from the incision made on abdominal wall. TAP blocks and local anaesthetic wound infiltration are believed to provide improved post-ope...
SARCOIDOSIS- A CLINICORADIOLOGICAL PROFILE OF 30 PATIENTS
BACKGROUND Sarcoidosis is an inflammatory multisystem granulomatous disease of unknown aetiology and predominantly affects the lungs, followed by eye, skin, peripheral lymph node, liver, spleen, heart, central nervous sy...